Maynards Europe (Maynards), a renowned global leader in auctioneering and asset management, in partnership with Divestiture, a leading dismantling, demolition, and remediation company, is excited to announce the upcoming sale of the contents of a complete pharmaceutical API (Active Pharmaceutical Ingredient) manufacturing facility. Formerly operated by Veronova, the facility's contents will be available through private treaty and online auction events, presenting a rare opportunity for businesses looking to enter or grow their presence in the pharmaceutical manufacturing industry.
Nestled within a secure 27-acre fenced area, the main production facility is part of a total site that spans 154 acres. This location is in Annan, Scotland, just 85 miles from both Edinburgh and Glasgow, and boasts stunning views of the coastline and the peaks of the Lake District across the water.
This facility, equipped with state-of-the-art machinery for API (Active Pharmaceutical Ingredient) production, is a highly valuable asset for buyers worldwide. The sale includes all manufacturing equipment, laboratory apparatus, processing systems, quality control labs, and supporting infrastructure, providing a comprehensive turnkey solution for pharmaceutical companies aiming to boost their production capabilities.
Commitment to Sustainability and Recycling
In line with Maynards' dedication to sustainability, the sale of this equipment presents an excellent opportunity to recycle and repurpose high-quality industrial assets. By acquiring well-maintained, used equipment in excellent condition, buyers can significantly reduce the need for new manufacturing, minimize environmental impact, and shorten lead times for acquiring new machinery.
"This project perfectly aligns with our partnership's core values of environmental responsibility and sustainable redevelopment," said Daniel Gray. "By repurposing existing assets and embracing eco-friendly practices, we are creating value for our customers and contributing to a more sustainable future."
Many of the facility's machines have been meticulously maintained, ensuring a smooth transition for the new owner without compromising on quality or functionality. This recycling and repurposing effort supports the broader industry's goals of enhancing environmental stewardship and reducing the carbon footprint of global manufacturing operations.
The Annan Pharmaceutical project follows the success of the Avara API facility, a 100-acre site previously handled by Maynards and Divestiture, where over 250,000 tonnes of material were successfully recycled.
Local Job Creation and Economic Benefits
"This facility has long been a cornerstone of local manufacturing," said Gray. "The sale of its assets and the potential for repurposing the buildings present an exciting opportunity to rejuvenate the local economy. We've already seen significant interest from potential occupiers looking to create high-quality jobs and bring employment back to the area. This sale offers a chance to revitalize the facility while preserving the region's strong legacy of industrial excellence".
Equipment Sale Details
The equipment is available for purchase through Private Treaty Sales and online auctions. Interested buyers are encouraged to arrange site visits and pre-auction inspections to fully evaluate the assets on offer. Maynards will offer comprehensive support throughout the process, ensuring a smooth and transparent experience for all parties involved. Relevant documentation, including equipment drawings, maintenance records, and service histories, is available upon request. Full dismantling, loading, and shipping services can also be arranged as needed. For more information, please visit: www.MaynardsEurope.com or email Europe@Maynards.com.
About Maynards
Maynards is a global leader in industrial services, specializing in the valuation and sale of surplus plant equipment and machinery. Our expertise covers the sale of entire manufacturing facilities, including process equipment, workshops, and general engineering machinery. Established in 1902, Maynards has grown to operate from seven permanent offices across Europe, Canada, the USA, Japan, and China. With over 122 years of experience, we are dedicated to delivering outstanding service to our clients. Each year, Maynards facilitates the reuse of more than 50,000 pieces of equipment through auctions and private treaty sales. For more information, visit Maynards.com.
For media inquiries, please contact: Gabriel Polzin e: Gabriel@maynards.com
About Divestiture
Divestiture specialises in entire and partial site decommissioning services, including decontamination, asbestos removal, dismantling, demolition, and ground remediation for blue-chip clients. Our expertise focuses on the pharmaceutical, chemical, petrochemical, and manufacturing industries.
For media inquiries, please get in touch with Bethany Palin e: Bethany.palin@divestiture.co.uk
Nestled within a secure 27-acre fenced area, the main production facility is part of a total site that spans 154 acres. This location is in Annan, Scotland, just 85 miles from both Edinburgh and Glasgow, and boasts stunning views of the coastline and the peaks of the Lake District across the water.
This facility, equipped with state-of-the-art machinery for API (Active Pharmaceutical Ingredient) production, is a highly valuable asset for buyers worldwide. The sale includes all manufacturing equipment, laboratory apparatus, processing systems, quality control labs, and supporting infrastructure, providing a comprehensive turnkey solution for pharmaceutical companies aiming to boost their production capabilities.
Commitment to Sustainability and Recycling
In line with Maynards' dedication to sustainability, the sale of this equipment presents an excellent opportunity to recycle and repurpose high-quality industrial assets. By acquiring well-maintained, used equipment in excellent condition, buyers can significantly reduce the need for new manufacturing, minimize environmental impact, and shorten lead times for acquiring new machinery.
"This project perfectly aligns with our partnership's core values of environmental responsibility and sustainable redevelopment," said Daniel Gray. "By repurposing existing assets and embracing eco-friendly practices, we are creating value for our customers and contributing to a more sustainable future."
Many of the facility's machines have been meticulously maintained, ensuring a smooth transition for the new owner without compromising on quality or functionality. This recycling and repurposing effort supports the broader industry's goals of enhancing environmental stewardship and reducing the carbon footprint of global manufacturing operations.
The Annan Pharmaceutical project follows the success of the Avara API facility, a 100-acre site previously handled by Maynards and Divestiture, where over 250,000 tonnes of material were successfully recycled.
Local Job Creation and Economic Benefits
"This facility has long been a cornerstone of local manufacturing," said Gray. "The sale of its assets and the potential for repurposing the buildings present an exciting opportunity to rejuvenate the local economy. We've already seen significant interest from potential occupiers looking to create high-quality jobs and bring employment back to the area. This sale offers a chance to revitalize the facility while preserving the region's strong legacy of industrial excellence".
Equipment Sale Details
The equipment is available for purchase through Private Treaty Sales and online auctions. Interested buyers are encouraged to arrange site visits and pre-auction inspections to fully evaluate the assets on offer. Maynards will offer comprehensive support throughout the process, ensuring a smooth and transparent experience for all parties involved. Relevant documentation, including equipment drawings, maintenance records, and service histories, is available upon request. Full dismantling, loading, and shipping services can also be arranged as needed. For more information, please visit: www.MaynardsEurope.com or email Europe@Maynards.com.
About Maynards
Maynards is a global leader in industrial services, specializing in the valuation and sale of surplus plant equipment and machinery. Our expertise covers the sale of entire manufacturing facilities, including process equipment, workshops, and general engineering machinery. Established in 1902, Maynards has grown to operate from seven permanent offices across Europe, Canada, the USA, Japan, and China. With over 122 years of experience, we are dedicated to delivering outstanding service to our clients. Each year, Maynards facilitates the reuse of more than 50,000 pieces of equipment through auctions and private treaty sales. For more information, visit Maynards.com.
For media inquiries, please contact: Gabriel Polzin e: Gabriel@maynards.com
About Divestiture
Divestiture specialises in entire and partial site decommissioning services, including decontamination, asbestos removal, dismantling, demolition, and ground remediation for blue-chip clients. Our expertise focuses on the pharmaceutical, chemical, petrochemical, and manufacturing industries.
For media inquiries, please get in touch with Bethany Palin e: Bethany.palin@divestiture.co.uk
